ﺑﺎﺯﮔﺸﺖ ﺑﻪ ﺻﻔﺤﻪ ﻗﺒﻠﯽ
خرید پکیج
تعداد آیتم قابل مشاهده باقیمانده : 3 مورد
نسخه الکترونیک
medimedia.ir

Cervical spondylotic myelopathy

Cervical spondylotic myelopathy
Literature review current through: Jan 2024.
This topic last updated: Jul 14, 2020.

INTRODUCTION — Cervical spondylosis refers to a progressive degenerative process affecting the cervical vertebral bodies and intervertebral discs. This process can lead to narrowing (stenosis) of the central spinal canal, ie, cervical spinal stenosis. If sufficiently severe, the cervical spinal cord is compressed, producing a syndrome of spinal cord dysfunction known as cervical spondylotic myelopathy. Myelopathy occurs in 5 to 10 percent of patients with symptomatic cervical spondylosis. Other clinical syndromes associated with cervical spondylosis include neck pain and cervical radiculopathy.

Cervical spondylotic myelopathy is the most common cause of myelopathy in adults over 55 years, causing progressive disability and impairing the quality of life [1-5].

Issues related to cervical spondylotic myelopathy will be reviewed here. Neck pain, cervical radiculopathy, spinal cord syndromes, and other spinal cord disorders are discussed separately. (See "Evaluation of the adult patient with neck pain" and "Clinical features and diagnosis of cervical radiculopathy" and "Anatomy and localization of spinal cord disorders" and "Disorders affecting the spinal cord".)

PATHOPHYSIOLOGY — Cervical spondylosis is a general term for nonspecific, degenerative changes of the cervical spine that are common in older adults. These changes include degeneration of the intervertebral discs resulting in disc herniation; facet, uncovertebral, and vertebral body osteophyte formation; and ossification and hypertrophy of the posterior longitudinal ligament and ligamenta flava. The pathogenesis of cervical spondylosis is discussed separately. (See "Clinical features and diagnosis of cervical radiculopathy", section on 'Cervical spondylosis'.)

These processes can lead to narrowing of the central cervical canal, ie, cervical spinal stenosis. This in turn can produce dysfunction of the adjacent spinal cord, as the combined result of mechanical compression of neural elements and spinal cord ischemia due to compression of the arterial and/or venous blood supply to the cord [3]. Flexion and extension of the neck may exacerbate compression; the canal diameter is reduced by 2 to 3 mm in flexion, while extension can cause inward buckling of the ligamentum flavum.

The neurologic syndrome of cervical spondylotic myelopathy is sometimes referred to as a radiculomyelopathy because the spondylotic process can simultaneously damage spinal nerve roots as well as the cord itself. Injury to the anterior horn cells in the spinal cord gray matter can also cause lower motor neuron deficits at the level of spinal cord involvement (see 'Clinical presentation' below). Because the C5-7 regions are most commonly affected, the lower motor neuron or segmental signs are generally observed in these myotomes.

CLINICAL PRESENTATION — Cervical spinal cord compression can give rise to weakness in the arms, legs, or both; sensory loss with a high thoracic or cervical sensory level; and urinary and rectal sphincter dysfunction [1].

There is no well-defined pattern of neurologic deficits in cervical spondylotic myelopathy. Patients present with varying signs and symptoms that can include:

Pain in the neck, subscapular region, or shoulder, often radiating into the arms.

Numbness or paresthesias in the arms. The sensory loss may follow a dermatomal pattern (figure 1), and often underlies complaints of loss of fine motor control in the hands.

Gait disturbance, usually characterized by a spastic, scissoring quality.

Sensory deficits, usually related to dorsal column function (reduced joint position and vibratory sense) and loss of pain sensation, can be elicited in the lower extremities and may contribute to the gait impairment.

Weakness in the lower extremities with upper motor neuron characteristics: increased reflexes, increased tone, and present Babinski signs.

Lower motor neuron findings (weakness, atrophy, and suppressed reflexes) in a myotomal distribution in the arms or hands. The C5-7 myotomes are most often affected (table 1).

Bladder dysfunction, urgency, frequency, and/or retention.

Lhermitte sign. An electric shock-like sensation in the neck, radiating down the spine or into the arms, produced by forward flexion of the neck.

Symptoms usually begin insidiously. Gait impairment is a common early symptom [6-8]. This is often ill described by the patient, who may complain of leg weakness or stiffness or of a vague unsteadiness. By the time a patient presents for surgical intervention, sensory deficits in the hands causing functional impairment are also a common complaint in 80 percent [7,9]. Clinical bladder dysfunction is less common, occurring in less than 20 percent [3,9]. The examination may also reveal crepitus of the neck with restriction of lateral flexion and rotation.

Patients with cervical spondylotic myelopathy may present with progressive bilateral sensory loss and motor dysfunction in the hands, without other neurologic symptoms. These symptoms can be misdiagnosed as carpal tunnel syndrome, but electrodiagnostic studies (nerve conduction studies and electromyography) will fail to support that diagnosis.

Some patients with cervical spondylotic myelopathy will present acutely, often after minor neck trauma (such as from a fall or a whiplash injury in a motor vehicle accident), with a central cord syndrome characterized by disproportionately greater motor impairment in the upper compared with the lower extremities, bladder dysfunction, and a variable degree of sensory loss below the level of injury [8,10,11] (see "Anatomy and localization of spinal cord disorders", section on 'Central cord syndromes'). It was previously thought that the injury in these cases was the result of a concussion of the cord with stasis of axoplasmic flow, causing edematous injury. However, autopsy studies have demonstrated that bleeding into the central cord is a more likely mechanism [10,11]. This is a rare event in patients who are asymptomatic prior to the trauma [12].

DIAGNOSIS — The diagnosis requires a careful correlation between findings from the history, physical examination, and imaging studies.

Imaging — Both magnetic resonance imaging (MRI) and computed tomography (CT) with myelography can be used to diagnose cervical spondylotic myelopathy, providing a quantitative assessment of central canal narrowing [13]. MRI is superior in providing intramedullary detail of spinal cord pathology, but CT provides better images of bone and other calcified tissues. Because it is noninvasive, MRI is generally considered the test of choice [6,13]. MRI is also useful to exclude other potential causes of cervical myelopathy. (See "Disorders affecting the spinal cord".)

Various measures of canal narrowing are used clinically and in research studies. The simplest of these, and perhaps the most commonly used in routine clinical practice, is a measure of the anterior-posterior diameter. Cervical spondylotic myelopathy is considered unlikely if the diameter exceeds 16 mm, and probable if less than 10 mm. Others use measures of canal area as a potentially more reliable measure of disease severity [14,15].

Spondylotic cord compression can be seen at one or more levels. One-third to one-half of patients have multilevel disease (image 1) [9,16]. Compression at more than one level usually correlates with more severe neurologic deficits and perhaps a worse prognosis [17].

Another potentially important marker of disease severity and prognosis is a finding of signal abnormality within the cord (intramedullary). However, investigators report mixed results when attempting to correlate neurologic impairment with this finding [4,17-20]. Hypointensity on T1-weighted images, though less frequently seen than hyperintensity on T2-weighted images, may be a more reliable marker of disease severity (image 1) [4,21]. Signal abnormality at multiple cord levels also appears to be a more significant finding than more restricted areas of signal change. Some studies have found that diffusion tensor imaging provided a better correlation with clinical findings compared with more traditional MRI techniques; however, its precise clinical utility remains to be established [22-24].

There is a high incidence of MRI abnormalities of the cervical spine in asymptomatic older individuals [25,26]. One study showed disc bulge or herniation in 57 percent, spinal cord impingement in 26 percent, and frank cord compression in 4 percent of patients over 64 years [25]. These findings worsen over time in most patients [26]. Careful clinical correlation between imaging studies and clinical features is necessary to diagnose cervical spondylotic myelopathy.

Electrophysiology — Electromyography and nerve conduction studies usually do not add to the diagnosis of cervical spondylotic myelopathy. However, these tests can provide information regarding the presence and degree of anterior horn cell or spinal nerve route damage and are useful to exclude other diagnoses, particularly amyotrophic lateral sclerosis (ALS). (See "Diagnosis of amyotrophic lateral sclerosis and other forms of motor neuron disease".)

Motor- and somatosensory-evoked potentials do not have a defined role in the clinical diagnosis of cervical spondylotic myelopathy. Though often giving abnormal results, sensitivities are low, and the observed abnormalities are not specific to cervical spondylotic myelopathy [7]. However, investigators are studying a potential role for these tests as well as transcranial magnetic stimulation in determining prognosis in patients with cervical spondylotic myelopathy both with and without surgical intervention [14,27-30].

DIFFERENTIAL DIAGNOSIS — Cervical spondylotic myelopathy is often unrecognized in its early stages. In later stages, when impairments are clinically evident, several alternative diagnoses may be suggested.

Amyotrophic lateral sclerosis — Both amyotrophic lateral sclerosis (ALS) and cervical spondylotic myelopathy present in older adults. The neurologic examination in both disorders often demonstrates mixed upper and lower motor neuron deficits. With cervical spondylotic myelopathy, lower motor neuron deficits and fasciculations are isolated to the affected cervical myotomes, but in ALS they often appear in the legs and cranial muscles (eg, tongue) as well. Sensory deficits are not expected in ALS, but these are also often subtle or absent in patients with cervical spondylotic myelopathy.

Further complicating this issue is that radiologic evidence of cervical spondylosis in asymptomatic adults with normal neurologic examinations is well documented [27], and may be an incidental and misleading finding in a patient with ALS. Cases are reported in which continued neurologic deterioration after surgical decompression for putative cervical spondylotic myelopathy was later attributed to ALS [31]. Electromyography is an important diagnostic aid in ALS. (See "Clinical features of amyotrophic lateral sclerosis and other forms of motor neuron disease" and "Diagnosis of amyotrophic lateral sclerosis and other forms of motor neuron disease".)

Other cervical cord disorders — Other pathologies can affect the cervical spinal cord and produce a syndrome similar to cervical spondylotic myelopathy. Some of the more common of these disorders are summarized in the table (table 2) and are discussed in detail separately. (See "Disorders affecting the spinal cord".)

Guillain-Barré syndrome — Guillain-Barré syndrome (GBS) and cervical spondylotic myelopathy can both present as a subacute progressive paraparesis or quadriparesis. Patients with GBS typically have reduced or absent reflexes and may have cranial nerve involvement, while patients with cervical spondylotic myelopathy usually have hyperreflexia and do not have cranial nerve involvement. However, these clinical signs may be absent early on in presentation and neuroimaging may be required to distinguish these diagnoses. (See "Guillain-Barré syndrome in adults: Pathogenesis, clinical features, and diagnosis".)

Normal pressure hydrocephalus — Sharing clinical features of gait impairment and bladder dysfunction, normal pressure hydrocephalus (NPH) can superficially resemble cervical spondylotic myelopathy. However, in NPH, some degree of cognitive dysfunction is usually apparent, the gait disorder is usually apractic rather than spastic in quality, and urinary dysfunction is accompanied by an indifference representing its probable frontal lobe origin. These features are distinct from those of cervical spondylotic myelopathy. (See "Normal pressure hydrocephalus".)

PROGNOSIS — The natural history of cervical spondylotic myelopathy is not well characterized [8]. Some patients experience a slow and stepwise deterioration, with worsening gait, leg and arm weakness, sensory changes, and pain [6]. Some patients experience prolonged periods of stability; however, abrupt worsening can occur, often following minor neck injuries [32-34].

Identification of clinical or radiographic risk factors for neurologic deterioration has been somewhat elusive. In one study of 45 patients treated conservatively, female gender and higher degrees of cervical mobility appeared to be risk factors for deterioration [35]. A larger canal area was predictive of a good outcome in one study, but not another [14,27]. Intramedullary signal abnormality on magnetic resonance imaging (MRI) was found not to be associated with deterioration in two studies [18,27]. Others have found that abnormal motor- and somatosensory-evoked potentials identify patients at risk for neurologic progression [7,14,27].

TREATMENT — Treatment options for cervical spondylotic myelopathy, specifically when and if to operate, remain controversial.

Conservative measures — Nonsurgical treatment often includes some form of cervical immobilization (soft collar or brace), restriction of high-risk activities and environments (eg, slippery surfaces, vigorous neck movement, heavy lifting, action sports), and pain management [18,28,36,37]. Patients should also take precautions to avoid whiplash while in vehicles, by adjusting the headrest to a position at the level of the occiput. Although some regimens also include exercises and cervical traction, other clinicians suggest that these are contraindicated in cervical spondylotic myelopathy [38-40]. There are no published data supporting the efficacy of any of these measures.

Pain control for neck pain in cervical spondylotic myelopathy may be achieved using various pharmacologic strategies including nonsteroidal anti-inflammatory agents and other analgesics, muscle relaxants, and antidepressant medications. This is discussed separately. (See "Management of nonradicular neck pain in adults".)

For the patient who defers surgical intervention or whose lesion is not severe, routine reassessment of symptoms and serial neurologic examinations are potentially valuable to identify clinical evidence of increasing cord compression. Patients should be advised to report symptoms suggesting increasing myelopathy, such as increasing bowel/bladder dysfunction, weakness, sensory loss, or gait instability. Repeat imaging should be considered when there are increasing neurologic deficits.

Surgical decompression — There is no consensus regarding the indications and timing for surgical treatment of cervical spondylotic myelopathy [1]. Although unsupported by clinical trial data, it is common clinical practice to consider surgical decompression in patients with progressive deterioration and/or a moderate or severe myelopathy causing disabling neurologic deficits [3]. For patients with mild clinical features of myelopathy, surgical consultation is recommended for those at risk for deterioration; examples include those with severe spinal cord compression on magnetic resonance imaging (MRI) and those with active lifestyles. When surgery is deferred, there should be close neurologic follow-up to assess for progressive deficits. Surgery to prevent neurologic injury in patients with asymptomatic cervical spondylotic disease is generally not recommended [12].

A number of different surgical procedures are used to treat cervical spondylotic myelopathy [1]. Anterior surgeries include cervical discectomy and corpectomy (removal of the central portion of the vertebral body) alone or in combination at single or multiple levels, often combined with a strut reconstruction (bridging the space between the end plates of the vertebral bodies) using bone or synthetic materials and plate fixation [16,41]. Posterior surgeries include laminectomy and laminoplasty (decompression and reconstruction of the laminae) [41,42]. It is not known which type of surgical procedure is best, as high-quality randomized trials are lacking [43-49]. Anterior surgeries directly decompress the pathologic lesion, but can be associated with complications such as dysphagia, graft extrusion, and cerebrospinal leaks and appear to be associated with higher reoperation rates [50]. Laminoplasty produces a more flexible spine but is not always technically possible and is associated with higher rates of C5 root injury.

Overall, 50 to 80 percent of patients are reported to be improved after surgery, while 5 to 30 percent are worse or subsequently deteriorate [9,16,42,51-55]. In one retrospective case series, benefit was apparent in the first postoperative week and maximized at approximately six months, after which recovery was marginal [56].

Investigators have attempted to identify factors that predict a good or poor response to surgery. However, for every clinical and radiologic feature reported to identify patients likely or not to benefit from surgery, there are studies both confirming and refuting an association [9,17,20,21,29,51-53,55,57-66]. Factors reported in some studies to predict a poor response to surgery include:

Older age

Intramedullary signal abnormality on MRI, especially if multisegmental and with abnormalities on T1- as well as T2-weighted images

More severe disability at the time of operation

Longer duration of symptoms preoperatively

Narrow canal size preoperatively

Multisegmental compression

Surgical complications occur in up to 16 percent of patients and include death in approximately 1 percent [9,16,41,42,52,53,60,67-71]. Cardiopulmonary complications are more common in older patients [72]. Common complications more specific to the surgery include:

Nerve or nerve root injury, usually C5 or C6, recurrent laryngeal nerve, may be permanent or temporary

Wound infections

Epidural hematoma

Dural tear

Failure of instrumentation (eg, nonunion)

Studies comparing surgical and conservative treatments are limited to two small, randomized trials in patients with mild disease and one nonrandomized prospective cohort study in patients with a broader range of disease severity [73]:

A prospective but nonrandomized study in 43 patients with cervical spondylotic myelopathy found that the 20 patients who had surgery had improved functional status, pain, and neurologic symptoms at one year compared with those who were treated conservatively [39]. Surgically treated patients had worse baseline deficits.

In another study, 49 patients with a mild functional deficit associated with mild to moderate cervical spondylotic myelopathy were assigned by coin toss to surgical versus conservative treatment [28]. Patients assigned to conservative treatment had a significantly better gait at six months but not at two years after treatment. A nearly statistically significant better gait at baseline in the conservatively treated group may have biased the results.

Another randomized trial of 68 patients with mild to moderate signs of myelopathy identified no differences in neurologic outcomes at two or three years between those who received medical versus surgical treatment [14,37,74].

Conservative measures should remain in place after surgical therapy. Reported cases suggest that postsurgical patients remain vulnerable to the effects of high degrees of cervical mobility and to the effects of minor neck injuries [62,75]. One study reported that recurrent spondylosis occurred at unoperated levels at a rate of 2 percent per year [9].

Patients with acute deterioration — The development of acute myelopathy may occur in patients with cervical spondylotic myelopathy, even with only mild or no baseline deficits. An acute myelopathy may also be the first presentation for a patient with cervical spondylotic myelopathy. Relatively minor neck trauma may be sufficient to produce significant spinal cord injury in this setting, although this appears to be relatively rare in patients who were previously asymptomatic [12,76]. Among a cohort of 199 patients with asymptomatic cervical spondylosis, 14 traumatic episodes occurred over a 44-month median follow-up period with no association with the development of symptomatic myelopathy [12].

This is a neurologic emergency, requiring immediate neuroimaging for anatomic confirmation and prompt neurosurgical or orthopedic consultation [76,77]. High-dose intravenous corticosteroid treatment reduces cord edema and has been shown to improve outcomes in patients with acute spinal cord injury when given within eight hours of the injury [78]. The typical regimen is 30 mg/kg methylprednisolone, followed by an infusion of 5.4 mg/kg per hour for the first 23 hours.

SOCIETY GUIDELINE LINKS — Links to society and government-sponsored guidelines from selected countries and regions around the world are provided separately. (See "Society guideline links: Upper spine and neck disorders".)

INFORMATION FOR PATIENTS — UpToDate offers two types of patient education materials, "The Basics" and "Beyond the Basics." The Basics patient education pieces are written in plain language, at the 5th to 6th grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10th to 12th grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.

Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on "patient info" and the keyword(s) of interest.)

Basics topics (see "Patient education: Central spinal cord syndrome (The Basics)")

SUMMARY AND RECOMMENDATIONS — Cervical spondylotic myelopathy is the most common cause of myelopathy in older adults.

Cervical spondylotic myelopathy results from a progressive degenerative process affecting the cervical vertebral bodies and intervertebral discs and causing compression of the neural and vascular elements in the adjacent cord. (See 'Pathophysiology' above.)

There is no specific stereotyped presentation of cervical spondylotic myelopathy. Usually symptoms begin with an insidious onset of gait disturbance. Other common symptoms include sensory loss, and weakness and muscle atrophy in the hands, along with neck and arm pain. The examination usually reveals other myelopathic features. (See 'Clinical presentation' above.)

Cervical spondylotic myelopathy must be distinguished from amyotrophic lateral sclerosis (ALS) and other cervical cord disorders. (See 'Differential diagnosis' above.)

The diagnosis of cervical spondylotic myelopathy is made by correlating the clinical features with findings of cervical spondylosis and cord compression seen on a neuroimaging study, usually magnetic resonance imaging (MRI). (See 'Diagnosis' above.)

The clinical course and prognosis of cervical spondylotic myelopathy is not well characterized. Patients can deteriorate progressively or in a stepwise fashion with long periods of stability. Some patients may deteriorate abruptly in association with a minor neck injury. (See 'Prognosis' above.)

There are no large randomized trials on which to base treatment recommendations. For patients with mild, nondebilitating myelopathy we suggest surgical consultation for those at risk of neurologic deterioration (eg, active lifestyle, severe radiologic cord compression) (Grade 2C). Close neurologic follow-up should assess for deterioration when surgery is deferred. Conservative measures include intermittent neck immobilization, pain management, and restriction of high-risk or aggravating activities. For patients with more severe myelopathy or progressing deficits, we suggest surgical decompression (Grade 2C). (See 'Treatment' above.)

Acute deterioration or an acute presentation with myelopathy in a patient with cervical spondylosis is a neurologic emergency. After confirmation of the diagnosis with MRI, patients should receive a surgical consultation. We suggest administration of intravenous methylprednisolone within eight hours of acute deterioration (Grade 2C). The standard dose is 30 mg/kg intravenous bolus, followed by an infusion of 5.4 mg/kg per hour for the first 23 hours. (See 'Patients with acute deterioration' above.)

  1. Theodore N. Degenerative Cervical Spondylosis. N Engl J Med 2020; 383:159.
  2. Montgomery DM, Brower RS. Cervical spondylotic myelopathy. Clinical syndrome and natural history. Orthop Clin North Am 1992; 23:487.
  3. McCormick WE, Steinmetz MP, Benzel EC. Cervical spondylotic myelopathy: make the difficult diagnosis, then refer for surgery. Cleve Clin J Med 2003; 70:899.
  4. King JT Jr, McGinnis KA, Roberts MS. Quality of life assessment with the medical outcomes study short form-36 among patients with cervical spondylotic myelopathy. Neurosurgery 2003; 52:113.
  5. Moore AP, Blumhardt LD. A prospective survey of the causes of non-traumatic spastic paraparesis and tetraparesis in 585 patients. Spinal Cord 1997; 35:361.
  6. Sadasivan KK, Reddy RP, Albright JA. The natural history of cervical spondylotic myelopathy. Yale J Biol Med 1993; 66:235.
  7. Lyu RK, Tang LM, Chen CJ, et al. The use of evoked potentials for clinical correlation and surgical outcome in cervical spondylotic myelopathy with intramedullary high signal intensity on MRI. J Neurol Neurosurg Psychiatry 2004; 75:256.
  8. Baron EM, Young WF. Cervical spondylotic myelopathy: a brief review of its pathophysiology, clinical course, and diagnosis. Neurosurgery 2007; 60:S35.
  9. Chiles BW 3rd, Leonard MA, Choudhri HF, Cooper PR. Cervical spondylotic myelopathy: patterns of neurological deficit and recovery after anterior cervical decompression. Neurosurgery 1999; 44:762.
  10. Morse SD. Acute central cervical spinal cord syndrome. Ann Emerg Med 1982; 11:436.
  11. Dickman CA, Hadley MN, Pappas CT, et al. Cruciate paralysis: a clinical and radiographic analysis of injuries to the cervicomedullary junction. J Neurosurg 1990; 73:850.
  12. Bednařík J, Sládková D, Kadaňka Z, et al. Are subjects with spondylotic cervical cord encroachment at increased risk of cervical spinal cord injury after minor trauma? J Neurol Neurosurg Psychiatry 2011; 82:779.
  13. Modic MT, Masaryk TJ, Mulopulos GP, et al. Cervical radiculopathy: prospective evaluation with surface coil MR imaging, CT with metrizamide, and metrizamide myelography. Radiology 1986; 161:753.
  14. Kadanka Z, Mares M, Bednarík J, et al. Predictive factors for mild forms of spondylotic cervical myelopathy treated conservatively or surgically. Eur J Neurol 2005; 12:16.
  15. Karpova A, Arun R, Davis AM, et al. Reliability of quantitative magnetic resonance imaging methods in the assessment of spinal canal stenosis and cord compression in cervical myelopathy. Spine (Phila Pa 1976) 2013; 38:245.
  16. Chagas H, Domingues F, Aversa A, et al. Cervical spondylotic myelopathy: 10 years of prospective outcome analysis of anterior decompression and fusion. Surg Neurol 2005; 64 Suppl 1:S1:30.
  17. Singh A, Crockard HA, Platts A, Stevens J. Clinical and radiological correlates of severity and surgery-related outcome in cervical spondylosis. J Neurosurg 2001; 94:189.
  18. Matsumoto M, Toyama Y, Ishikawa M, et al. Increased signal intensity of the spinal cord on magnetic resonance images in cervical compressive myelopathy. Does it predict the outcome of conservative treatment? Spine (Phila Pa 1976) 2000; 25:677.
  19. Harrop JS, Naroji S, Maltenfort M, et al. Cervical myelopathy: a clinical and radiographic evaluation and correlation to cervical spondylotic myelopathy. Spine (Phila Pa 1976) 2010; 35:620.
  20. Zhang YZ, Shen Y, Wang LF, et al. Magnetic resonance T2 image signal intensity ratio and clinical manifestation predict prognosis after surgical intervention for cervical spondylotic myelopathy. Spine (Phila Pa 1976) 2010; 35:E396.
  21. Arvin B, Kalsi-Ryan S, Mercier D, et al. Preoperative magnetic resonance imaging is associated with baseline neurological status and can predict postoperative recovery in patients with cervical spondylotic myelopathy. Spine (Phila Pa 1976) 2013; 38:1170.
  22. Kerkovský M, Bednarík J, Dušek L, et al. Magnetic resonance diffusion tensor imaging in patients with cervical spondylotic spinal cord compression: correlations between clinical and electrophysiological findings. Spine (Phila Pa 1976) 2012; 37:48.
  23. Uda T, Takami T, Tsuyuguchi N, et al. Assessment of cervical spondylotic myelopathy using diffusion tensor magnetic resonance imaging parameter at 3.0 tesla. Spine (Phila Pa 1976) 2013; 38:407.
  24. Banaszek A, Bladowska J, Podgórski P, Sąsiadek MJ. Role of Diffusion Tensor MR Imaging in Degenerative Cervical Spine Disease: a Review of the Literature. Clin Neuroradiol 2016; 26:265.
  25. Teresi LM, Lufkin RB, Reicher MA, et al. Asymptomatic degenerative disk disease and spondylosis of the cervical spine: MR imaging. Radiology 1987; 164:83.
  26. Okada E, Matsumoto M, Ichihara D, et al. Aging of the cervical spine in healthy volunteers: a 10-year longitudinal magnetic resonance imaging study. Spine (Phila Pa 1976) 2009; 34:706.
  27. Bednarik J, Kadanka Z, Dusek L, et al. Presymptomatic spondylotic cervical cord compression. Spine (Phila Pa 1976) 2004; 29:2260.
  28. Bednarík J, Kadanka Z, Vohánka S, et al. The value of somatosensory- and motor-evoked potentials in predicting and monitoring the effect of therapy in spondylotic cervical myelopathy. Prospective randomized study. Spine (Phila Pa 1976) 1999; 24:1593.
  29. Uchida K, Nakajima H, Sato R, et al. Multivariate analysis of the neurological outcome of surgery for cervical compressive myelopathy. J Orthop Sci 2005; 10:564.
  30. Funaba M, Kanchiku T, Imajo Y, et al. Transcranial magnetic stimulation in the diagnosis of cervical compressive myelopathy: comparison with spinal cord evoked potentials. Spine (Phila Pa 1976) 2015; 40:E161.
  31. Yamada M, Furukawa Y, Hirohata M. Amyotrophic lateral sclerosis: frequent complications by cervical spondylosis. J Orthop Sci 2003; 8:878.
  32. Firooznia H, Ahn JH, Rafii M, Ragnarsson KT. Sudden quadriplegia after a minor trauma. The role of preexisting spinal stenosis. Surg Neurol 1985; 23:165.
  33. Whiteson JH, Panaro N, Ahn JH, Firooznia H. Tetraparesis following dental extraction: case report and discussion of preventive measures for cervical spinal hyperextension injury. J Spinal Cord Med 1997; 20:422.
  34. Park MS, Moon SH, Lee HM, et al. The natural history of degenerative spondylolisthesis of the cervical spine with 2- to 7-year follow-up. Spine (Phila Pa 1976) 2013; 38:E205.
  35. Barnes MP, Saunders M. The effect of cervical mobility on the natural history of cervical spondylotic myelopathy. J Neurol Neurosurg Psychiatry 1984; 47:17.
  36. Yoshimatsu H, Nagata K, Goto H, et al. Conservative treatment for cervical spondylotic myelopathy. prediction of treatment effects by multivariate analysis. Spine J 2001; 1:269.
  37. Kadanka Z, Bednarík J, Vohánka S, et al. Conservative treatment versus surgery in spondylotic cervical myelopathy: a prospective randomised study. Eur Spine J 2000; 9:538.
  38. Mink JH, Gordon RE, Deutsch AL. The cervical spine: radiologist's perspective. Phys Med Rehabil Clin N Am 2003; 14:493.
  39. Sampath P, Bendebba M, Davis JD, Ducker TB. Outcome of patients treated for cervical myelopathy. A prospective, multicenter study with independent clinical review. Spine (Phila Pa 1976) 2000; 25:670.
  40. Mazanec D, Reddy A. Medical management of cervical spondylosis. Neurosurgery 2007; 60:S43.
  41. Carette S, Fehlings MG. Clinical practice. Cervical radiculopathy. N Engl J Med 2005; 353:392.
  42. Wang MY, Shah S, Green BA. Clinical outcomes following cervical laminoplasty for 204 patients with cervical spondylotic myelopathy. Surg Neurol 2004; 62:487.
  43. Edwards CC 2nd, Heller JG, Murakami H. Corpectomy versus laminoplasty for multilevel cervical myelopathy: an independent matched-cohort analysis. Spine (Phila Pa 1976) 2002; 27:1168.
  44. Oh MC, Zhang HY, Park JY, Kim KS. Two-level anterior cervical discectomy versus one-level corpectomy in cervical spondylotic myelopathy. Spine (Phila Pa 1976) 2009; 34:692.
  45. Cunningham MR, Hershman S, Bendo J. Systematic review of cohort studies comparing surgical treatments for cervical spondylotic myelopathy. Spine (Phila Pa 1976) 2010; 35:537.
  46. Hirai T, Okawa A, Arai Y, et al. Middle-term results of a prospective comparative study of anterior decompression with fusion and posterior decompression with laminoplasty for the treatment of cervical spondylotic myelopathy. Spine (Phila Pa 1976) 2011; 36:1940.
  47. Sakai K, Okawa A, Takahashi M, et al. Five-year follow-up evaluation of surgical treatment for cervical myelopathy caused by ossification of the posterior longitudinal ligament: a prospective comparative study of anterior decompression and fusion with floating method versus laminoplasty. Spine (Phila Pa 1976) 2012; 37:367.
  48. McAfee PC, Reah C, Gilder K, et al. A meta-analysis of comparative outcomes following cervical arthroplasty or anterior cervical fusion: results from 4 prospective multicenter randomized clinical trials and up to 1226 patients. Spine (Phila Pa 1976) 2012; 37:943.
  49. Delamarter RB, Zigler J. Five-year reoperation rates, cervical total disc replacement versus fusion, results of a prospective randomized clinical trial. Spine (Phila Pa 1976) 2013; 38:711.
  50. Bridwell KH, Anderson PA, Boden SD, et al. What's new in spine surgery. J Bone Joint Surg Am 2013; 95:1144.
  51. Lunsford LD, Bissonette DJ, Zorub DS. Anterior surgery for cervical disc disease. Part 2: Treatment of cervical spondylotic myelopathy in 32 cases. J Neurosurg 1980; 53:12.
  52. Kumar VG, Rea GL, Mervis LJ, McGregor JM. Cervical spondylotic myelopathy: functional and radiographic long-term outcome after laminectomy and posterior fusion. Neurosurgery 1999; 44:771.
  53. Ebersold MJ, Pare MC, Quast LM. Surgical treatment for cervical spondylitic myelopathy. J Neurosurg 1995; 82:745.
  54. Cheung WY, Arvinte D, Wong YW, et al. Neurological recovery after surgical decompression in patients with cervical spondylotic myelopathy - a prospective study. Int Orthop 2008; 32:273.
  55. Machino M, Yukawa Y, Hida T, et al. Persistent physical symptoms after laminoplasty: analysis of postoperative residual symptoms in 520 patients with cervical spondylotic myelopathy. Spine (Phila Pa 1976) 2012; 37:932.
  56. Acharya S, Srivastava A, Virmani S, Tandon R. Resolution of physical signs and recovery in severe cervical spondylotic myelopathy after cervical laminoplasty. Spine (Phila Pa 1976) 2010; 35:E1083.
  57. Shibuya R, Yonenobu K, Yamamoto K, et al. The motor conduction of cervical spondylotic myelopathy with intramedullary high signal intensity on MRI. International Congress Series 2005; 1278:253.
  58. Papadopoulos CA, Katonis P, Papagelopoulos PJ, et al. Surgical decompression for cervical spondylotic myelopathy: correlation between operative outcomes and MRI of the spinal cord. Orthopedics 2004; 27:1087.
  59. Chen CJ, Lyu RK, Lee ST, et al. Intramedullary high signal intensity on T2-weighted MR images in cervical spondylotic myelopathy: prediction of prognosis with type of intensity. Radiology 2001; 221:789.
  60. Hasegawa K, Homma T, Chiba Y, et al. Effects of surgical treatment for cervical spondylotic myelopathy in patients > or = 70 years of age: a retrospective comparative study. J Spinal Disord Tech 2002; 15:458.
  61. Yamazaki T, Yanaka K, Sato H, et al. Cervical spondylotic myelopathy: surgical results and factors affecting outcome with special reference to age differences. Neurosurgery 2003; 52:122.
  62. Ogawa Y, Chiba K, Matsumoto M, et al. Postoperative factors affecting neurological recovery after surgery for cervical spondylotic myelopathy. J Neurosurg Spine 2006; 5:483.
  63. Fernández de Rota JJ, Meschian S, Fernández de Rota A, et al. Cervical spondylotic myelopathy due to chronic compression: the role of signal intensity changes in magnetic resonance images. J Neurosurg Spine 2007; 6:17.
  64. Morio Y, Teshima R, Nagashima H, et al. Correlation between operative outcomes of cervical compression myelopathy and mri of the spinal cord. Spine (Phila Pa 1976) 2001; 26:1238.
  65. Yagi M, Ninomiya K, Kihara M, Horiuchi Y. Long-term surgical outcome and risk factors in patients with cervical myelopathy and a change in signal intensity of intramedullary spinal cord on Magnetic Resonance imaging. J Neurosurg Spine 2010; 12:59.
  66. Karpova A, Arun R, Davis AM, et al. Predictors of surgical outcome in cervical spondylotic myelopathy. Spine (Phila Pa 1976) 2013; 38:392.
  67. Greiner-Perth R, Elsaghir H, Böhm H, El-Meshtawy M. The incidence of C5-C6 radiculopathy as a complication of extensive cervical decompression: own results and review of literature. Neurosurg Rev 2005; 28:137.
  68. Nassr A, Eck JC, Ponnappan RK, et al. The incidence of C5 palsy after multilevel cervical decompression procedures: a review of 750 consecutive cases. Spine (Phila Pa 1976) 2012; 37:174.
  69. Haller JM, Iwanik M, Shen FH. Clinically relevant anatomy of recurrent laryngeal nerve. Spine (Phila Pa 1976) 2012; 37:97.
  70. Leonard R, Belafsky P. Dysphagia following cervical spine surgery with anterior instrumentation: evidence from fluoroscopic swallow studies. Spine (Phila Pa 1976) 2011; 36:2217.
  71. Lee MJ, Konodi MA, Cizik AM, et al. Risk factors for medical complication after cervical spine surgery: a multivariate analysis of 582 patients. Spine (Phila Pa 1976) 2013; 38:223.
  72. Fineberg SJ, Ahmadinia K, Patel AA, et al. Incidence and mortality of cardiac events in lumbar spine surgery. Spine (Phila Pa 1976) 2013; 38:1422.
  73. Fouyas IP, Statham PF, Sandercock PA. Cochrane review on the role of surgery in cervical spondylotic radiculomyelopathy. Spine (Phila Pa 1976) 2002; 27:736.
  74. Kadanka Z, Mares M, Bednaník J, et al. Approaches to spondylotic cervical myelopathy: conservative versus surgical results in a 3-year follow-up study. Spine (Phila Pa 1976) 2002; 27:2205.
  75. Dickerman RD, Lefkowitz M, Epstein JA. A traumatic central cord syndrome occurring after adequate decompression for cervical spondylosis: biomechanics of injury: case report. Spine (Phila Pa 1976) 2005; 30:E611.
  76. Chen TY, Dickman CA, Eleraky M, Sonntag VK. The role of decompression for acute incomplete cervical spinal cord injury in cervical spondylosis. Spine (Phila Pa 1976) 1998; 23:2398.
  77. Ishida Y, Tominaga T. Predictors of neurologic recovery in acute central cervical cord injury with only upper extremity impairment. Spine (Phila Pa 1976) 2002; 27:1652.
  78. Bracken MB, Shepard MJ, Collins WF, et al. A randomized, controlled trial of methylprednisolone or naloxone in the treatment of acute spinal-cord injury. Results of the Second National Acute Spinal Cord Injury Study. N Engl J Med 1990; 322:1405.
Topic 4820 Version 11.0

References

آیا می خواهید مدیلیب را به صفحه اصلی خود اضافه کنید؟